Vape Dojo Corporate Headquarters

Warning LetterOpen

United StatesFEI 3012070217Issued Apr 12, 2024Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3012070217.

Violations0

Issue DateApr 12, 2024

Product TypeTobacco

StatusOpen

Letter Details

Firm: Vape Dojo Corporate Headquarters
Location: United States
FEI Number: 3012070217
Country: United States
Issue Date: April 12, 2024
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Based on limited metadata, the FDA issued a Warning Letter on April 12, 2024, to Vape Dojo Corporate Headquarters regarding tobacco products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's tobacco product regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional details regarding the particular compliance issues would require review of the complete Warning Letter.

Vape Dojo Corporate Headquarters FDA Warning Letter, April 12, 2024